Welcome to JDD Corner, your gateway to a world of dermatology knowledge and insights! JDD Corner is a curated collection of video abstracts, editor picks, Key Opinion Leader (KOL) spotlights, trending articles, and much more. Whether you are a dermatologist, a skincare enthusiast, or simply curious about the latest advancements in dermatology, JDD Corner is your one-stop destination for staying informed and up-to-date with the most exciting developments in the field. Explore our carefully selected content and immerse yourself in the dynamic world of dermatology. Welcome to JDD Corner!
JDD Corner
JDD Corner
Video Abstracts
Introducing an Exciting NEW Opportunity for Our Authors to Connect with Our Readership through a Cutting-Edge Media Channel! Email us at editorial@jddonline.com to get started!
NEW! VIDEO ABSTRACT
Clinical Evaluation of a Thiamidol-Based Regimen With SPF Compared With SPF Alone for Facial Hyperpigmentation
Hyperpigmentation disorders are common skin concerns that negatively impact patient quality of life and self-perception. Hyperpigmentation results from the overproduction of melanin via a multi-step process with a rate-limiting step catalyzed by tyrosinase.
NEW! VIDEO ABSTRACT
Molecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis
Seborrheic dermatitis(SD) is a chronic inflammatory skin disease that affects sebaceous areas, typically the face and scalp, with an estimated prevalence of 2% to 5%. It is thought to result from a combination of immune dysregulation, barrier dysfunction, and colonization with Malassezia species.1,2
NEW! VIDEO ABSTRACT
Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation
Cutaneous hyperpigmentation, which includes melasma, post-inflammatory hyperpigmentation, and solar lentigines, significantly impacts patients’ quality of life.
NEW! VIDEO ABSTRACT
Retrospective Review of Dermal Safety Studies of Organic Sunscreens
Sunscreens can reduce skin cancer and sunburn. Recent studies on dermal penetration have raised concerns about the safety of sunscreens with organic ultraviolet (UV) filters.
NEW! VIDEO ABSTRACT
Perceptions and Recommendations for Sunscreen: A Cross-Sectional Survey of United States Dermatology Healthcare Providers
The dermatology HCPs in this survey strongly support sunscreen use and believe that FDA-approved sunscreens are effective and safe. The social media findings highlight a continued need to improve education on sunscreen use and increase counseling from clinicians on sun protection behaviors.
NEW! VIDEO ABSTRACT
Open-Label Study: Over-the-Counter Oat Flour/Oat Oil/ Oat Extract-containing Lotion With Avenanthramides for Sensitive Skin and Psoriasis
Psoriasis is a common skin condition that affects the physical and emotional well-being of patients. Moisturizers have been shown to significantly improve skin condition and quality of life in this patient population. Skin afflictions such as atopic dermatitis and pruritis share etiological similarities with psoriasis, and oatmeal (Avena sativa)-containing lotion has proven effective in treating the symptoms of those conditions. However, data on the use of an over-the-counter oatmeal-containing lotion alone to treat the symptoms of psoriasis are limited.
Author Spotlight
Our current Author Spotlight features Michael H. Gold MD, one of the co-authors of “Exosomes in Cosmetic Dermatology: A Review of Benefits and Challenges,” published in JDD’s January 2026 issue. In addition to his article, Dr. Gold also answered questions about the current state of dermatology and how the field is adapting to new advances in technology and treatments.
Read More
Trending Articles
Brodalumab’s 8-Year Journey in Plaque Psoriasis: Insights Into Efficacy, Safety, and Real-World Evidence
Plaque psoriasis is a chronic immune-mediated disease driven by proinflammatory cytokines. Brodalumab—a recombinant, human monoclonal antibody that functions as an interleukin-17 receptor A blocker—was approved in 2017 in the United
States for treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic or phototherapy and have failed to respond to/have lost response to other systemic therapies. While efficacy and safety of brodalumab for moderate-to-severe plaque psoriasis were demonstrated across phase 2 and 3 clinical trials, long-term data from these trials and several real-world studies have
since been published.
Read More
Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements From an Expert Panel
Advanced topical nonsteroidal therapies are expanding options for atopic dermatitis (AD) by providing targeted anti-inflammatory control without many limitations of long-term topical corticosteroids. As these agents become more available, practical guidance is needed on their use as first-line therapy, proactive maintenance, combination regimens, safety, and long-term management.
Read More
Updates on Therapeutic Approaches for Management of Androgenetic Alopecia
Androgenetic alopecia (AGA) is a common, progressive form of nonscarring hair loss, affecting both men and women. Its pathogenesis is largely driven by androgenic factors, including elevated dihydrotestosterone (DHT), leading to follicular miniaturization. While FDA-approved treatments like minoxidil and finasteride are standard, off-label therapies and emerging treatments continue to evolve. This systematic review examines the current and emerging treatment landscape for AGA, focusing on various topical, oral, injectable, and non-pharmacological interventions.
Read More
Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss on the scalp and body, leading to a reduced quality of life and psychosocial burden for patients. The only US Food and Drug Administration–approved treatments for severe AA are the Janus kinase inhibitors (JAKis) baricitinib, ritlecitinib, and deuruxolitinib. Herein, we discuss the efficacy, safety, and real-world aspects of JAKi treatment for patients with AA for an advanced practice provider audience. We review the clinical characteristics and diagnosis of AA and discuss treatment expectations for patients using JAKis.
Read More
From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy
lopecia areata (AA) is an autoimmune condition marked by non-scarring, patchy hair loss of the scalp which progresses in <10% of cases to alopecia totalis (AT), which is marked by complete hair loss from the scalp, eyebrows, and eyelashes. AA is prevalent in pediatric patients and is associated with atopic dermatitis (AD). The interleukin (IL)-4 and IL-13 antagonist dupilumab is approved for use in both pediatric and adult patients with AD and asthma. However, in some cases, dupilumab has shown promising results in regrowing hair in patients with concurrent AA.
Read More
A Decade of Hair Prosthetic Injuries: A Review of United States Emergency Department Cases (2013-2022)
Hair prosthetics are widely used to improve the quality of life standards for patients suffering from a variety of hair conditions, such as alopecia.1
Read More
Recent News
Editor's Picks
Video Pearls
Tough Day at the Office: Lupus, Sarcoidosis, and a Side of Morphea
Watch as Dr. Friedman shares basic principles to managing three distinct diseases – cutaneous lupus, sarcoidosis and linear morphea. Learn why you need to do a good review of organ systems and be prepared to phone a friend (or more) across the aisle in medicine.
Tips for Providing Better Atopic Dermatitis Care
With the growing list of therapeutic options, Dr. Friedman encourages clinicians to go back to the basics and address one of the greatest challenges — treatment adherence.
Acne and Diet
Adam Friedman, professor and chair of dermatology at GW School of Medicine and Health Sciences. Dr. Friedman says acne is an evidence-based example of the saying “you are what you eat.”
Crushing It In The Capital: Lessons From Residency Translated
Dr. Friedman provides his tips for remaining calm during the craziest of office visits. He also shares why being fun, creative and an off-label bandit matters.
New Innovations in Hyperpigmentation
Dr. Chilukuri outlines at-home and in-office treatments to address hyperpigmentation, including newly developed therapies.
